Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23032625 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
Condition: Carcinoma
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: Erlotinib;   Other: Treatment determined by physician

Indicates status has not been verified in more than two years